Bryan Johnson's protocol, item by item: what the trials say
Reviewed 27 sourcesPublished by PepVault
Bryan Johnson's published protocol, item by item: each supplement, prescription drug, diet, exercise and sleep habit, graded by what human trials found.

- Last reviewed
- Sources
- 27
- Questions
- 7
- Compounds
- 9
The short answer
Bryan Johnson's published protocol is daily exercise, a fixed 8:30 pm bedtime, a 2,250-calorie plant-heavy diet finished by noon, a supplement stack and a list of prescription drugs. The best-backed parts are the plainest: the weekly exercise target and an olive-oil diet. Evolocumab and empagliflozin have large outcome trials in heart and diabetes patients. Omega-3's large trial was null, and several items rest on mouse or uncontrolled data.
Evidence: Mixed by item: a WHO guideline for exercise; large randomized outcome trials for the olive-oil diet, evolocumab, empagliflozin, metformin and acarbose, mostly in people with heart disease, diabetes or high blood sugar; randomized marker trials for calorie restriction, ashwagandha, collagen and oral minoxidil; observational data for sleep regularity and sauna; small uncontrolled studies for hyperbaric oxygen; mice only for acarbose's lifespan effect.

What is in Bryan Johnson's protocol?
Everything below is as published on his protocol page, protocol.bryanjohnson.com, read on November 20, 2026; the page carries no version number and is signed "Planet Earth, 2026"1. Its stated goal is in its name: "Don't Die." It is a timed day, from a 5 am measurement to an 8:30 pm bedtime, plus sections on exercise, sleep, food, skin, hair and past therapies, and it calls itself an experimental clinical research project1.
Each item gets one grade from human trials. Strong: large randomized trials on outcomes such as heart attacks or deaths. Moderate: randomized trials on a marker, such as sleep scores. Weak: small, uncontrolled or observational studies, where people who chose a habit are compared with people who did not. The page's own branded blends are left out; this guide grades single ingredients.

Which supplements does he take, and do they work?
The morning drink and breakfast carry the stack: creatine, three prebiotic fibres, collagen, omega-3, and an ashwagandha-and-rhodiola capsule1. Creatine has the strongest record; omega-3 has the largest trial, and it came back flat.
| Item | Amount on the page | What human trials found | Grade |
|---|---|---|---|
| Creatine | 7.5 g a day (5 g plus 2.5 g in a mix)1 | More strength and lean mass with training; better memory in one trial of older adults2 | Strong for muscle |
| Omega-3 (EPA/DHA) | 800 mg1 | 25,871 adults, 1 g a day for 5.3 years: no fewer major heart events, cancers or deaths than placebo3 | Strong, and null |
| Ashwagandha | One capsule with rhodiola1 | 5 trials, 400 adults: a small but real sleep gain, larger with insomnia, at 600 mg or more and after 8 weeks4 | Moderate |
| Rhodiola | Same capsule1 | 11 trials on fatigue, every one at high or unclear risk of bias; results contradict each other5 | Weak |
| Collagen peptides | 11 g plus a scoop; the page advises 20 to 30 g a day1 | 19 trials, 1,125 people, 95% women: better skin hydration, elasticity and wrinkles over about 90 days6 | Moderate for skin |
Three items have their own guides tonight. Creatine's brain, bone and kidney results are in Creatine beyond muscle. The page names nicotinamide riboside among its stack's ingredients1; how NR compares with NMN and NAD+ injections is in NAD+ vs NMN vs NR. Magnesium appears in the page's sections for women, at 100 to 200 mg a day1; which form does what is in Magnesium glycinate vs citrate vs threonate.
Which prescription drugs are on the list?
The midday "Rx stack" lists eight drugs; a separate prescription section adds candesartan and gives acarbose as 400 mg a day where the timed day says 200 mg1. Two of the eight, Armour Thyroid 60 mg and levothyroxine 100 mcg, are listed for diagnosed hypothyroidism: treatment of a diagnosis, not a longevity item1. Starting any drug below is a decision for you and your doctor.
| Drug, as listed | The trial or label | What it found | Grade |
|---|---|---|---|
| Evolocumab (Repatha), 140 mg every other week | FOURIER: 27,564 people with heart disease, already on a statin7 | LDL cholesterol down 59%, from 92 to 30 mg/dL; heart events 9.8% against 11.3%7 | Strong, in heart disease |
| Empagliflozin (Jardiance), 10 mg | EMPA-REG OUTCOME: 7,020 people with type 2 diabetes at high heart risk8 | Heart deaths 3.7% against 5.9%; deaths from any cause 5.7% against 8.3%8 | Strong, in diabetes |
| Metformin, 500 mg, six weeks on and off | Diabetes Prevention Program: 3,234 adults with high blood sugar, 850 mg twice a day9 | 31% fewer new cases of diabetes; the lifestyle program cut them 58%9 | Strong for diabetes prevention |
| Acarbose, 200 mg (400 mg in the Rx section) | STOP-NIDDM: 1,429 adults with impaired glucose tolerance11 | Diabetes in 32% against 42%; gas and diarrhoea were the commonest side effects11 | Strong for diabetes prevention; lifespan in mice |
| Tadalafil, 5 mg | The FDA label13 | Approved for erectile dysfunction and an enlarged prostate's urinary symptoms13 | Labelled uses only |
| Candesartan, 8 mg | The FDA label14 | Approved for high blood pressure and heart failure; lowering blood pressure cuts strokes and heart attacks14 | Strong, with high blood pressure |
| Oral minoxidil, 3.75 mg | 90 men with pattern hair loss, oral 5 mg against topical 5% for 24 weeks16 | Oral was not better than topical overall; it won on the crown in photographs16 | Moderate for hair |
Two of these come with a twist. In 53 adults around 62 who trained for 12 weeks, metformin blunted the gains in insulin sensitivity and aerobic fitness the exercise produced10; how it compares with berberine and a GLP-1 is in Berberine vs metformin vs a GLP-1. Acarbose's aging case comes from mice, where it lengthened male median lifespan by 22% and female by 5%12. The page itself rests empagliflozin's longevity case on animal experiments1.
Oral minoxidil tablets are labelled only for severe high blood pressure that other drugs cannot control15; for hair they are used off-label at lower amounts, and in the hair trial the commonest effects were extra body hair in 49% and headache in 14%16. Topical tretinoin, listed at 0.025 to 0.1%1, has a 1988 trial behind it: 14 of 15 people who used it on the face for 16 weeks showed less sun damage, against none on plain cream17.
When to get help On oral minoxidil, a quick gain of five pounds or more, or new swelling in the face, hands or ankles, is a reason to call your prescriber15.
What does he eat, and is it backed?
The page sets 2,250 calories a day, which it calls 10% below the recommended intake, with 130 g of protein, 206 g of carbohydrate and 101 g of fat. Three of the four meals get a tablespoon of extra virgin olive oil, the food is mostly vegetables, legumes, berries and nuts, and the last meal is at noon1.
- Eating less: moderate. In CALERIE, 218 healthy adults aged 21 to 50 were asked to cut 25% and managed 11.9%, from 2,467 to 2,170 calories. Over two years they lost 7.5 kg and improved LDL cholesterol, blood pressure, inflammation and insulin sensitivity18, and the DunedinPACE measure of how fast people age slowed a little while other aging clocks did not move19. The page's 10% is close to what they achieved.
- Finishing food early: moderate, from one small trial. Men with prediabetes who ate within six hours with dinner before 3 pm, for five weeks, had better insulin sensitivity and blood pressure without losing weight20.
- Olive oil: strong. In PREDIMED, of 7,447 adults at high heart risk, those given a Mediterranean diet with extra virgin olive oil had 31% fewer major heart events than a low-fat control diet (hazard ratio 0.69)21.
Commonly reported: people who copy the plan say the noon cut-off and the 8:30 pm bedtime are the hardest parts to keep, and that they sleep more soundly once they do.
How does he exercise and sleep, and how well is that supported?
The exercise section asks for six hours a week: three strength and three cardio sessions, with 150 minutes of conversational Zone 2 work and 75 minutes of hard intervals, plus a few minutes of movement every 30 minutes of sitting1. That clears both halves of the World Health Organization's adult guideline, 150 to 300 minutes of moderate or 75 to 150 of vigorous activity a week, with strength work22. Grade: strong, from a guideline built on systematic reviews; the best-supported habit on the page.
Sleep is a fixed 8:30 pm bedtime, screens off an hour before, no caffeine or alcohol 8 to 10 hours before, and a room at 65 to 70°F; the page says consistency matters as much as the hour1. In 60,977 UK Biobank adults wearing activity trackers, people in the four more regular fifths had a 20% to 48% lower risk of death than the least regular fifth, and regularity predicted it better than total sleep23. Grade: weak to moderate, because the study is observational.
What about the sauna, the oxygen chamber and the past therapies?
Sauna, 20 minutes at 175°F daily: weak, but striking. In 2,315 Finnish men followed for about 21 years, deaths from any cause were 49.1% among once-a-week users and 30.8% among those who went four to seven times a week, and the link held after adjusting for heart risk factors24. The men chose their habit, so this is observational. The page's ice pack on the groin is for fertility1, and with reason: in 10 men, two 15-minute sessions a week at 80 to 90°C for three months cut sperm count and motility, which fully recovered six months after stopping25.
Hyperbaric oxygen: weak. The page lists 60 sessions breathing pure oxygen at twice normal air pressure1. In 35 healthy adults aged 64 and older given 60 sessions, telomeres in several blood cell types lengthened by over 20%, but the study had no control group26.
Past therapies. The page lists a follistatin gene therapy in October 20231; its only human trial treated six men with Becker muscular dystrophy, and four walked farther afterwards27. It lists three months of daily Cerebrolysin injections with no measured effect1; the trials are in What is Cerebrolysin? The trial evidence. The skin and hair items, from red light to peptide serums, start in GHK-Cu for skin and hair.
How would you test one part of it on yourself?
The page measures before it changes: blood work every three to six months and a body-composition reading each morning1. You can test one item the same way.
- Pick one item from the strong or moderate rows, not the whole stack, so you can tell what did what.
- Get baseline blood work for the markers that item is meant to move, such as LDL cholesterol, HbA1c or fasting glucose.
- Keep the item and its amount the same for 8 to 12 weeks, about the length of the marker trials above.
- Repeat the same tests at the same lab, at the same time of day, and compare.
PepVault logs each supplement or prescription as part of your protocol, with reminders, so a missed fortnight shows up before the retest does. Set reminders in PepVault
Its bloodwork panels track LDL, ApoB, HbA1c, fasting glucose, hs-CRP and TSH over time. Log it in PepVault
Sources
- Johnson B. Bryan Johnson's protocol (Don't Die). protocol.bryanjohnson.com, signed "Planet Earth, 2026", read November 20, 2026. protocol.bryanjohnson.com
- Kreider RB et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017. PubMed 28615996
- Manson JE et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (VITAL). N Engl J Med. 2019. PubMed 30415637
- Cheah KL et al. Effect of Ashwagandha (Withania somnifera) extract on sleep: a systematic review and meta-analysis. PLoS One. 2021. PubMed 34559859
- Ishaque S et al. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012. PubMed 22643043
- de Miranda RB et al. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021. PubMed 33742704
- Sabatine MS et al. Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER). N Engl J Med. 2017. PubMed 28304224
- Zinman B et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes (EMPA-REG OUTCOME). N Engl J Med. 2015. PubMed 26378978
- Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002. PubMed 11832527
- Konopka AR et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019. PubMed 30548390
- Chiasson JL et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002. PubMed 12086760
- Harrison DE et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014. PubMed 24245565
- CIALIS (tadalafil) tablets, prescribing information, section 1 Indications and Usage. Eli Lilly and Company. DailyMed. dailymed.nlm.nih.gov
- ATACAND (candesartan cilexetil) tablets, prescribing information, section 1 Indications and Usage. ANI Pharmaceuticals. DailyMed. dailymed.nlm.nih.gov
- Minoxidil tablets, prescribing information: Indications and Usage, and Information for Patients. American Health Packaging. DailyMed. dailymed.nlm.nih.gov
- Penha MA et al. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024. PubMed 38598226
- Weiss JS et al. Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA. 1988. PubMed 3336176
- Kraus WE et al. 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. Lancet Diabetes Endocrinol. 2019. PubMed 31303390
- Waziry R et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nat Aging. 2023. PubMed 37118425
- Sutton EF et al. Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 2018. PubMed 29754952
- Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (PREDIMED). N Engl J Med. 2018. PubMed 29897866
- Bull FC et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020. PubMed 33239350
- Windred DP et al. Sleep regularity is a stronger predictor of mortality risk than sleep duration: a prospective cohort study. Sleep. 2024. PubMed 37738616
- Laukkanen T et al. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Intern Med. 2015. PubMed 25705824
- Garolla A et al. Seminal and molecular evidence that sauna exposure affects human spermatogenesis. Hum Reprod. 2013. PubMed 23411620
- Hachmo Y et al. Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial. Aging (Albany NY). 2020. PubMed 33206062
- Mendell JR et al. A phase 1/2a follistatin gene therapy trial for Becker muscular dystrophy. Mol Ther. 2015. PubMed 25322757
Newsletter · Weekly
The weekly peptide briefing.
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.